Erectile Dysfunction Drug-Patent Found Obvious

BAYER PHARMA AG, v. WATSON LABS, INC.: Nov. 1, 2017. Before Lourie, Moore, and O’Malley   Takeaway: The CAFC will reverse a finding of non-obviousness where key references are missing from a district court’s opinion and mere concerns over effectiveness do not rise to the level of teaching away. Procedural Posture: Alleged …